The withdrawal of Redux (dexfenfluramine) and Pondimin (fenfluramine) leaves lots of unanswered questions

October 1997

The withdrawal of Redux (dexfenfluramine) and Pondimin (fenfluramine) leaves lots of unanswered questions.

How many patients might have heart valve problems...who should get an ECHO...and whether these problems are reversible.

Researchers now suggest that 30% of patients on Redux or Pondimin might have leaky heart valves.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote